Overview

IV Paracetamol, Dexketoprofen or Morphine for the Treatment of Low Back Pain

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
0
Participant gender:
All
Summary
This randomized, controlled trial evaluates the analgesic efficacy and safety of intravenous single-dose paracetamol, dexketoprofen and morphine for the treatment of low back pain.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pamukkale University
Treatments:
Acetaminophen
Dexketoprofen trometamol
Morphine
Criteria
Inclusion Criteria:

- Adults (aged 16 to 55 years) with acute low back pain were eligible for inclusion in
the study- -

Exclusion Criteria:

- Exclusion criteria included known allergy or contraindication to morphine,
paracetamol,dexketoprofen or any opioid analgesic

- Hemodynamic instability

- Fever (temperature >38°C [100.4°F])

- Evidence of peritoneal inflammation

- Documented or suspected pregnancy

- Known or suspected aortic dissection or aneurysm, lombar disc hernia

- Use of any analgesic within 6 hours of ED presentation

- Previous study enrollment.

- Patients with known renal, pulmonary, cardiac, or hepatic failure, as well as those
with renal transplantation, were also excluded.